Hepatology - Hepatology Xagena

Hepatology

News

Drugs

Xagena Medicine

Xagena.net

Chronic hepatitis C: Taribavirin reduces anemia and increases sustained virologic response

Terlipressin treatment for gastrointestinal bleeding may lead to neurological complications

Chronic hepatitis C: men experience sexual dysfunction during antiviral therapy

HCV protease inhibitor Telaprevir improves response, halves treatment time for patients with chronic hepatitis C

Women with a history of hypothyroidism linked to significantly higher risk of developing liver cancer

Chronic hepatitis C: drinking coffee slows progression of liver disease

HBV exposure may increase risk for pancreatic cancer

Once-weekly Pegasys allows to achieve viral clearance in patients not responding to Peg-Intron in HCV patients

Increased risk of non-Hodgkin lymphoma linked to hepatitis C infection

Liver transplant recipients with hepatitis C: survival does not improve

Transient elastography: severe portal hypertension may be predicted by liver stiffness

Liver transplant: risk factors for diabetes mellitus

Chronic hepatitis C: treatment with Interferon linked to retinopathy

HepaGam B to prevent hepatitis B reinfection in liver transplant patients, FDA approved

New strategy for the treatment of liver fibrosis: CB1 cannabinoid receptor antagonism

Cirrhosis related to non-alcoholic steatohepatitis: ascites is the most common complication

Intrahepatic cholestasis during pregnancy linked to other liver diseases later in life

Hepatitis C: weight loss improves the efficacy of therapy

Lower risk for alcohol-related liver disease linked to coffee drinking

Chronic hepatitis in children undergoing liver transplant

Increased risk of heart disease linked to nonalcoholic fatty liver disease

Liver transplant can be successful in HIV patients with hepatitis B

Epivir to prevent hepatitis B relapse during chemotherapy

Hepatitis C: serum viral levels recur rapidly after liver transplant

Cyclosporine inhibits HCV virus in vitro

Cholestatic liver damage may be associated with an immune response affecting the central nervous system

Hepatitis C: difficulty in treating older patients with Interferon and Ribavirin

Primary biliary cirrhosis: causes

Children with chronic hepatitis C: Interferon with Ribavirin is safe and effective

Cystic fibrosis: liver transplant may not be indicated for patients with bleeding complication

Next Pages [1] 2

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions